期刊文献+

截敏祛风汤联合氯雷他定治疗过敏性鼻炎临床疗效观察 被引量:4

Clinical observation of "Jiemin Qufeng Decoction" plus loratadine in treating allergic rhinitis
在线阅读 下载PDF
导出
摘要 目的探讨截敏祛风汤联合氯雷他定汤治疗过敏性鼻炎的临床疗效。方法将120例过敏性鼻炎患者随机分为治疗组和对照组各60例,对照组给予氯雷他定治疗,治疗组给予截敏祛风汤联合氯雷他定治疗,治疗3个疗程后评定临床疗效。结果治疗组临床综合疗效总有效率为96.7%,显著高于对照组的73.3%(P<0.05);治疗组中医证候疗效总有效率为95.0%,显著高于对照组的73.3%(P<0.05);两组治疗后症状、体征总积分均显著下降(P<0.05),且治疗组总积分显著低于对照组(P<0.05)。结论截敏祛风汤联合氯雷他定能显著改善过敏性鼻炎患者的临床症状和体征。 Objective To investigate the clinical effects of "Jiemin Qufeng Decoction" plus loratadine in treating allergic rhinitis(AR). Methods 120 subjects were randomly divided into two groups: control group in which 60 cases were given loratadine and treatment group in which 60 cases were given "Jiemin Qufeng Decoc- tion" plus loratadine. After 3-course treatment, the clinical effects were evaluated. Results In the treatment group, the total effective rate for comprehensive clinical efficacy was 96.7% , higher than 73.33% in the control group( P 〈0.05 ) ; the total effective rate for TCM syndrome was 95.0%, higher than 73.3% in the control group( P 〈0.05 ). The symptoms and signs' total scores of the two groups were significantly decreased after treatment( P 〈0.05 ), with more significant decrease in the treatment group than in the control group(P 〈0.05 ). Conclusion "Jiemin Qufeng Decoction" plus loratadine is quite effective in improving the clinical symptoms of allergic rhinitis.
作者 朱小勇
出处 《上海中医药杂志》 2010年第4期43-44,共2页 Shanghai Journal of Traditional Chinese Medicine
关键词 过敏性鼻炎 中西医结合疗法 截敏祛风汤 氯雷他定 Allergic rhinitis integrative Chinese and westem medicine " Jiemin Qufeng Decoction" loratadine
  • 相关文献

参考文献5

二级参考文献23

  • 1鹿道温,王明辉,赵畔波,王志军.变态反应性鼻炎的中医辨证分型与变态反应学指标的相关性研究[J].中国中西医结合耳鼻咽喉科杂志,1996,4(3):112-114. 被引量:44
  • 2[5]陈国丰,徐轩,干千.干祖望耳鼻喉科医案选粹[M].北京:人民卫生出版社,2000:446-447.
  • 3中华医学会耳鼻咽喉科学分会 中华耳鼻咽喉科杂志编辑委员会.变应性鼻炎诊断及疗效评定标准[J].中华耳鼻咽喉科杂志,1998,33(3):134-134.
  • 4赵金铎.中医证候鉴别诊断学[M].北京:人民卫生出版社,1990.132,141.
  • 5Anjuli, Nayak, George Philip, et al. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall [J]. Allergy, Asthma & Immunology, 2001, 88 (6): 592-600.
  • 6P Ratner, F Hampel, J Van bavel, et al. Efficacy and safety of ebastine 20 mg compared to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled study [J]. Int Arch Allergy Immunol, 2004, 133:371-379.
  • 7F Hampel, W Howland, J Van Brvel, et al. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ebastine (20 mg and 10 mg ) to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis [J]. J Invest Allergol Immunol, 2004, 14 (1): 56-63.
  • 8Howard M, Druce MD, William R, et al. Brompheniramine, loratadine, and placebo in allergic rhinitis: a placebo-controlled compatative clinical trial [J]. J Clin Pharmacol, 1998, 38: 382- 389.
  • 9Chalmers TC, Celano P, Sacks HS, et al. Bias in treatment assignment in controlled clinical trials[J].N Engl J Med, 1983, 309 (354): 1358-1361.
  • 10Pawankar R. Allergic rhinitis and asthma: the link, the new ARIA classification and global approaches to treatment [J]. Curr Opin Allergy Clin Immunol, 2004, 4 ( 1 ) : 1-4.

共引文献1727

同被引文献73

引证文献4

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部